Skip to main content
. 2016 Sep 26;113(41):E6145–E6152. doi: 10.1073/pnas.1607843113

Fig. 3.

Fig. 3.

In vitro verification of induction of CYP1A mRNA by laquinimod. (A) CYP1A1 (Left) and CYP1A2 (Right) fold-induction in human hepatocytes treated with laquinimod for 24 h compared with vehicle controls. Experiments were repeated at least four times with cells from different donors. (B) Cyp1a1 fold-induction in mouse hepatocytes treated with laquinimod for 4 (Left) or 24 h (Right). Experiments were repeated at least four times with different donors.